Jewish News 24 · Nov 12, 2026
Jewish News 24 — photo status
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump. Health Secretary Robert F. Kennedy Jr. said his department is awarding up to $4.9 million to prepare for the first U.S. studies of ibogaine for post-traumatic stress disorder, a hard-to-treat condition linked to higher suicide and substance abuse rates among veterans.
More from Jewish News 24
- Jewish News 24Nov 13, 2026 · NEW: BROOKLYN D.A. OPENS CRIMINAL PROBE INTO DEADLY BUILDING

- Jewish News 24Nov 13, 2026 · The Supreme Court agreed Friday to consider President Donald

- Jewish News 24Nov 13, 2026 · UPDATE: MICROSOFT APOLOGIZES AS SERVICES RECOVER FROM MAJOR

- Jewish News 24Nov 13, 2026 · AMBASSADOR DANON: After an emotional and meaningful visit to

- Jewish News 24Nov 13, 2026 · 🇺🇸 TREASURY SECRETARY BESSENT DEFIES IRANIAN DEATH THREATS

- Jewish News 24Nov 13, 2026 · 🇮🇱🔴 IDF ELIMINATES OVER 10 TERRORISTS IN GAZA: The IDF an
